Trial Profile
F 18 T807 Tau PET Imaging of Older (≥ 40 Years Old) HIV Infected (HIV+) and HIV Uninfected (HIV-) Individuals (IND 123119, Protocol G)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Sep 2020
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Neurodegenerative disorders
- Focus Diagnostic use
- 17 Sep 2020 Status changed from active, no longer recruiting to completed.
- 28 May 2020 Status changed from recruiting to active, no longer recruiting.
- 13 Jul 2018 Planned number of patients changed from 60 to 80.